Androgen deprivation therapy is ineffective for early prostate cancer, US study showsBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2230 (Published 20 March 2014) Cite this as: BMJ 2014;348:g2230
- Susan Mayor
Men with early prostate cancer who are treated with androgen deprivation therapy instead of surgery or radiation therapy show no reduction in mortality compared with those who receive no treatment, a retrospective analysis of US cancer registries has shown.1
“This study is the most comprehensive study on the effectiveness of primary androgen deprivation therapy for men who forgo radiation and surgery for their localized prostate cancer, and it tells us there is no strong reason to use it in most patients,” said Arnold Potosky, lead author and professor of oncology and director of health services research at the Georgetown …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial